Axinn partner Delphine Knight Brown and counsel Jeny Maier spoke at ACI's 4th Annual Women Leaders in Life Sciences Law conference in Boston. 

During "Trump Administration: Keeping Ahead of the Changes," Delphine Knight Brown participated in a panel discussion focused on the changes to regulatory agencies, including the USPTO and FDA, as well the DOJ's latest enforcement priorities under the Trump administration.

During "M&A in the Life Sciences Industry: Impacts from Antitrust to IP and Beyond," Jeny Maier and other panelists discussed the far-reaching impacts of M&A transactions in the Life Sciences industry and how those in other practice areas will be impacted.